Related Experiment Videos
[UV-microspectrophotometric and flow cytometric analysis of the same samples using DAPI/HP staining]
N Tanaka1, S Ohtsuka, M Matsuyama
1Biomedical Laboratory, Yamanashi Hospital of Social Insurance.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1993
Summary
A novel DAPI/hematoporphyrin double staining method enhances UV-microspectrophotometry and flow cytometry accuracy for cytology and histopathology. This technique improves evaluation of borderline lesions and malignancy grading.
Area of Science:
- Biomedical Imaging and Cytometry
- Molecular Pathology
Context:
- Accurate cell and nuclear size, and nuclear-to-cytoplasmic (N/C) ratio measurements are crucial in histopathology and cytology.
- Existing staining methods like FITC and PI have limitations in accuracy for these measurements.
Purpose:
- To introduce a simple, one-step double staining technique using DAPI and hematoporphyrin (HP) for simultaneous UV-microspectrophotometry (UV-MSPM) and flow cytometry (FCM) analysis.
- To enable precise measurement of DNA content, total protein, nuclear size, cell size, and N/C ratio in various biological specimens.
- To enhance the evaluation and differentiation of borderline lesions, malignancy grading, and assessment of oncostatic treatment effectiveness.
Summary:
- A one-step DAPI/hematoporphyrin (HP) double staining protocol was developed for UV-microspectrophotometry (UV-MSPM) and flow cytometry (FCM) on fresh biopsy, surgical materials, paraffin sections, and smears.
- This method preserves cytoplasm for accurate cell size and N/C ratio measurements, with DAPI quantifying DNA and HP quantifying total protein.
- DAPI/HP staining demonstrated superior accuracy compared to FITC and PI, enabling detailed morphometric analysis for improved diagnostic capabilities.
Impact:
- The combined UV-MSPM and FCM approach with cell sorting offers significant advantages in cytology and histopathology for precise diagnostic evaluations.
- This technology has the potential to be integrated with automated cytologic screening systems like CYBEST for advanced morphometric analysis.
- Improved accuracy in evaluating borderline lesions, malignancy grade, and treatment response can lead to better patient management and therapeutic strategies.